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Background
Gadolinium is a contrast agent considered as safe for
magnetic resonance imaging (MRI). We report a patient
with a low grade astrocytoma who had two anaphylactic
reactions after administration of Gadobutrol and Gado-
terate Meglumine respectively in a routine brain MRIs.
Method
A 58-year old woman with low grade astrocytoma, who had
previously tolerated Gadolinium-based contrasts, was diag-
nosed with anaphylaxis to Gadobutrol by history of anaphy-
laxis after intravenous administration and positive skin
testing. For these reasons Gadobutrol administration was
banned and was given a premedication protocol (steroids
and antihistamines) if the patient will require future admin-
istrations of other Gadolinium-based agents. However, one
year later, despite premedication the patient presented with
pruritus and hives disseminated, breathlessness, dizziness
and hypotension two minutes after administration of Gado-
terate Meglumine in a control brain MRI. Skin testing with
Gadoterate meglumine, and Gadopentetic acid was carried
out. Histamine and isotonic saline were used as positive
and negative controls respectively.
Results
The results of skin testing (prick and intradermal) with
Gadoterate Meglumine and Gadopentetic acid were
negative. Histamine and isotonic saline were used as
positive and negative controls respectively. Intravenous
challenge with Gadoterate meglumine was not performed
by the suggestive clinical diagnosis of anaphylaxis and
history of Gadobutrol anaphylaxis (IgE-mediated). For
the severity of reactions, future administrations of Gado-
linium-based contrasts were banned in the patient.
Conclusions
We present a case of IgE-mediated anaphylaxis to Gado-
butrol and anaphylactic reaction with Gadoterate
Meglumine in a patient with low grade astrocytoma.
The anaphylactic reactions to referred contrasts could
be explained by cross-reactivity.
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